Chief Digital and Artificial Intelligence Office provides the latest report. The Department of Defense reported that its artificial intelligence (AI) office successfully concluded a pilot program that tested…
Read MoreMedication
Federal Court Rules in Favor of Generic Drug Competition in Patent Case
The court orders the removal of improper patent listings, clearing the path for lower-cost medications. The Federal Circuit U.S. Court of Appeals recently upheld a lower court’s decision…
Read MoreFDA Approves Medication for Rare Adrenal Gland Disorder
Crenessity reduces glucocorticoid dependency and improves hormone control for classic CAH. The FDA has recently approved Crenessity (crinecerfont) for use alongside glucocorticoids in treating adults and children aged…
Read MoreMedicare Proposal Expands Access to Care and Consumer Protections
CMS seeks to enhance Medicare Advantage and Part D programs, including coverage for anti-obesity medications. The Centers for Medicare and Medicaid Services (CMS) recently proposed updates to Medicare…
Read MoreEfforts Underway to Restore IV Fluid Supply in Hurricane Disruption of NC Facility
Federal agencies and Baxter International collaborate to boost IV fluid availability following severe storm damage. Hurricane Helene caused damage to Baxter International’s North Cove facility in North Carolina,…
Read MoreSupreme Court Declines Appeal by Former Pharma Executive
The court upholds the $64 million penalty, holding the former CEO liable for price gouging and fraud. The Supreme Court declined to hear an appeal filed by former…
Read MoreFDA Approves New Schizophrenia Treatment with a Breakthrough Mechanism
Cobenfy offers an alternative that addresses symptoms of schizophrenia with a different approach. The U.S. Food and Drug Administration (FDA) recently approved Cobenfy (xanomeline and trospium chloride) for…
Read MoreMedicare Announces Maximum Drug Prices After Negotiations
HHS secretary states that the negotiations will save Americans $3.7 billion in the first year. Medicare announced its first finalized list of drug price maximums for 10 prescription…
Read MoreHHS Announces Funding for HIV Medication Assistance
$1.4 billion allotted to help 560,000 patients afford life-saving drug. The Department of Health and Human Services (HHS) announced over $1.4 billion has been allocated to HIV medication…
Read MoreFDA Approves First TCR Gene Therapy for Synovial Sarcoma
Tecelra treats rare cancer through immunotherapy. The U.S. Food and Drug Administration (FDA) has approved Tecelra (afamitresgene autoleucel), a gene therapy for adults with unresectable or metastatic synovial…
Read More